Δημοσιεύσεις %1

Τμήμα Ιατρικής

Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης

Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.

+ Προσθέστε μια νέα δημοσίευση

Contact Info

Submitted by Απόστολος Τσάπας on Tue, 05/29/2018 - 01:51

Read more about Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:07

Read more about Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:09

Read more about Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:09

Read more about The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:09

Read more about Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:10

Read more about Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:10

Read more about Reporting completeness in abstracts of systematic reviews of diagnostic test accuracy studies in cardiovascular diseases is suboptimal.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:10

Read more about The relationship between early symptom severity, improvement and remission in first episode psychosis with jumping to conclusions.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:11

Read more about Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:11

Read more about Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:12

Read more about Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:12

Read more about GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:12

Read more about Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:13

Read more about Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:13

Read more about Fluid volume regulation in patients with heart failure.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:13

Read more about GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:14

Read more about KDIGO made 12 recommendations for managing diabetes with CKD.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:14

Read more about Satisfaction and Perceived Barriers of General Practice Residents in Relation to Their Educational Needs Coverage During Residency in Greece.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:15

Read more about Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:15

Read more about In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:16

Read more about Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:17

Read more about Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:18

Read more about Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:18

Read more about Some glucose-lowering drugs reduce risk for major adverse cardiac events.

Contact Info

Submitted by Απόστολος Τσάπας on Wed, 10/12/2022 - 09:18

Read more about Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

The prognostic value of right ventricular ejection fraction by cardiovascular magnetic resonance in heart failure: A systematic review and meta-analysis.

Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.

Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events.

Reporting completeness in abstracts of systematic reviews of diagnostic test accuracy studies in cardiovascular diseases is suboptimal.

The relationship between early symptom severity, improvement and remission in first episode psychosis with jumping to conclusions.

Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis.

Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis.

Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters.

GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.

Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.

Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.

Fluid volume regulation in patients with heart failure.

GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.

KDIGO made 12 recommendations for managing diabetes with CKD.

Satisfaction and Perceived Barriers of General Practice Residents in Relation to Their Educational Needs Coverage During Residency in Greece.

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.

In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.

Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.

Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.

Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.

Some glucose-lowering drugs reduce risk for major adverse cardiac events.

Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

Σύνδεσμοι

Το πανεπιστήμιο

Προσωπικό & Φοιτητές

Επικοινωνία

Primary tabs

Συνδεθείτε